Eiger BioPharmaceuticals

North America Legal Chronicle. July 16, 2024

Amylyx Pharmaceuticals’ Acquisition of Phase 3-Ready Asset from Eiger BioPharmaceuticals

By Leila Ahmed

Ropes & Gray represented Amylyx Pharmaceuticals in the transaction and Sidley Austin represented Eiger BioPharmaceuticals. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx) announced the acquisition of a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Otis Worldwide Corporation’s $1.5 Billion Notes Offering

Pathway Power’s Innovative Interconnection Financing Facility With Rabobank

Pathway Power’s Innovative Interconnection Financing Facility With Rabobank

CNH Industrial Capital Argentina’s US$28 Million Notes Issuance

Acqualimp’s Acquisition of Tigre

LHG Mining’s R$3.6 Billion Financing

Co-native’s Acquisition of Retune Group

Almaviva S.p.A.’s Bond Offering To Financing The Acquisition Of Iteris, Inc.

Readily Diagnostics’ Capital Raising

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Gordon Technologies’ Acquisition of Vertex Downhole Trading

Polyrizon’s $4.2 Million Initial Public Offering

Nala Renewables’ Financing Of 99.2MW Onshore Wind Project In Romania

Intudo’s US$125 Million Closing of Intudo Ventures IV and Natural Resources Fund

Downhole Products Limited’s Acquisition of Sledgehammer Oil Tools Private Limited

LGT Crestone’s Acquisition of Commonwealth Private Advice

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

Amylyx Pharmaceuticals’ Acquisition of Phase 3-Ready Asset from Eiger BioPharmaceuticals

Standard 1 Year Membership Required